 Photo courtesy of NIAID/NIH When Tulane's new BSL-3 lab opens at its
national primate center in Covington, researchers will be required to
wear protective gear that guards workers from potential hazards. This
photo was taken at another of the country's BSL-3 labs. |
It's a chilly day, and Robert Johnson,
communications director for the Tulane National Primate Research
Center, leads a small tour of the newest facility at the center's
Covington complex. The afternoon sun glints off the modern
steel-and-glass structure. A dozen workers buzz in and out of the
building, carrying spools of wire and tubs of epoxy.
"Watch your step," Johnson says over the
whir of a drill. "And watch your head."
Everyone in the group has been outfitted
with a hard hat and strict instructions to take no photographs. The
nearly finished work-in-progress is a biosafety level 3 laboratory
(BSL3), and security is important. The building is the future site of
research into vaccines and therapies for federally regulated infectious
diseases like tuberculosis, plague and typhus.
After two years and $27.5 million in
construction, the lab is one of 13 Regional Biosafety Labs (RBLs)
scattered across the country. Heavily subsidized by the National
Institutes of Health (NIH) and the National Institute of Allergy and
Infectious Diseases (NIAID), the RBL network is part of the National
Biodefense Program developed in the wake of the anthrax scare of 2001.
It is an infrastructure of intellectual and physical capital designed
to protect the public from biological threats — naturally
occurring and otherwise.
This tour is a rare opportunity to peek
inside a BSL3 before it is commissioned. After the building's ribbon
cutting on Dec. 5, the lab will close to everyone but the scientists
and technicians who work there.
Standing at the doorway to the complex, the
space smells of new asphalt and fresh paint. Soon, there will be no
such smell — soon, the air inside will be so clean, so perfectly
filtered, that, according to the director of the center, people who
suffer from seasonal allergies will find respite working there.
That is, of course, if they make it past
the front door.
"You're at more risk driving from here to
New Orleans than you are working in the lab," says Dr. Andrew Lackner,
director of the Primate Research Center.
He quickly rattles off a score of security
measures that occur even before the research begins in the RBL. A
career scientist specializing in veterinary medicine and emerging
infectious diseases, Lackner is acutely aware of how safe the lab
actually is versus public perception of lab safety. After all, labs
like this are a favorite template for Hollywood thrillers
(Outbreak) and horror movies (I Am Legend and the
28-Time-Units-Later franchise).
"The first thing to remember is that we
know exactly what we're working with when we're working with it, as
opposed to, say, somebody walking into a hospital in New Orleans off of
a plane with a fever," Lackner says. "(In that case) it could be a
common cold, it could be anything. In our case, we know what we
have."
Employees at the center are already
intimately familiar with level 3 labs and protocols for nonhuman
primate (monkey) trials. The center's facilities have included a BSL3
for more than 20 years, and the center is certified to work with
"select agents" — the euphemism for federally regulated
bacterial, viral and toxic pathogens. The center's breeding colonies of
more than 4,000 monkeys have long made it an attractive resource for
researchers studying models of diseases and therapeutics in primates.
In fact, many of the first projects that will be run through the new
RBL will be transferred from the old lab.
"Biodefense is essentially making vaccines,
diagnostics, therapeutics against infectious agents," Lackner says,
stressing the lab will not be a weapons factory. "Those terms often get
used synonymously — and they are anything but — with
bioterror, bioweapons and biowarfare. ... Those are things that are
designed to hurt people."
Before any researchers can even get to the
front door of the lab, they are vetted through a multifaceted security
screening. Anyone who needs to work with the select agents must first
be fingerprinted and pass a Department of Justice background check
— on top of the criminal background check and academic degree
verification required of all Tulane employees in these positions.
Researchers then undergo a health exam to ensure they are not ill and
can safely wear the necessary protective equipment.
 An architectural rendering of the BSL-3 lab facility, scheduled to open soon at the Tulane National Primate Center in Covington. |
Researchers also must have a substantial
NIH grant to be considered for a spot in the new lab. The granting
process is its own informal screening mechanism. Any proposals to the
NIH are peer-reviewed and assessed on the basis of the study's ethical,
technical and potential scientific merits. Only one in 10 investigators
who apply for these kinds of NIH grants win funding. Investigators then
compete for lab space. The RBL will create 60 new jobs, including
animal handler and lab technician support positions.
"There are people backed up at the door
now. ... NIH investigators with funded grants," Lackner says.
One of the researchers who already earned
real estate in the new RBL is Dr. Chad Roy, a microbiology faculty
member at the center and the Tulane School of Medicine. The
aerobiologist — someone who studies how pathogens are transmitted
through the air — will continue to work on studies he started in
the old BSL3 as well as a vaccine study of Eastern equine
encephalitis.
"It's an absolutely phenomenal resource,"
Roy says. "The nonhuman primate provides an ideal model to study the
disease." He's excited about the upgraded features of the new RBL
— not the least of which is breathing room. The facility is
almost 39,000 square feet, and nearly half of that is lab space. There
are also posh offices at the building's entrance.
Roy has worked with bacteria and viruses in
level 3 and level 4 labs across the country — including the
United States Army Medical Research Institute for Infectious Diseases
(USAMRIID), made famous in Richard Preston's bookss The Hot Zone
and The Demon in the Freezer — and prefers level 3 labs
like the RBL.
"In level 4 you're wearing one of the big
blue suits you see in the movies," he says. The cumbersome gear limits
mobility, and dressing out of the space suits is a necessarily
time-consuming process because the viruses studied in BSL4 labs are
largely fatal and incurable. (In the BSL3 labs, like Tulane's RBL,
there are vaccines and antibiotics that work for the majority of the
pathogens studied.) "BSL4 is a pain in the butt to work in and that's
why I don't work there," Roy says.
Not that the investigators at the RBL in
Covington won't be wearing serious personal protective equipment. After
entering the offices of the RBL, researchers headed for the "wet labs"
where live agents and pathogens will be present will change into
scrubs. They will then enter an antechamber where they suit up in
positive-pressure, full-head respirators, so if a leak develops in the
mask, air will rush out of the respirator, limiting the chance for
contamination. Everyone inside the lab wears two sets of latex gloves,
and nothing worn inside the "dirty areas" ever leaves the lab.
The whole building is a fortress designed
so nothing exposed to contaminants leaves the lab. Air entering and
exiting the lab is HEPA filtered to remove all particulate matter. The
interior surfaces are coated with a special epoxy paint that keeps
bacteria from sticking to the walls and ceiling. The doors are hung on
continuous hinges that prevent leakage between rooms. All waste from
the lab is processed through a high-pressure chemical digester,
obliterating any trace of organic matter.
Like the theory behind the headgear, the
building is maintained at negative pressure so if it were structurally
damaged, air would rush into the building instead of out of it. The
likelihood of that ever happening is small; the structure stands on
piles that go approximately 80 feet into the ground and it is designed
to withstand winds up to 350 mph.
Then there are the redundancies: multiple
HEPA filters, multiple backup-generators and multiple cameras in every
lab space. Before any researchers set up shop in the lab, every system
will undergo testing.
"There will be a 21-day test where the
building is up and running," says Jesse Shurtz, the general
superintendent for Gilbane Inc., the construction company building the
RBL. "You cause calculated failures on some of the systems to make sure
that it recovers and it operates properly."
Even personnel security has built-in
redundancies. "I thought they were joking when they said, 'retinal
scans,'" Roy says. They were not. Along with special identification
cards, lab workers will have to pass eye scans to enter the labs.
The RBL ribbon cutting coincides with the
Tulane University 2008 Presidential Symposium: "Emerging Infectious
Diseases and Global Risk." Representatives from the NIH and possibly
Gov. Bobby Jindal will be on hand to christen the building. The
ceremony will be an invitation-only affair, though a lecture by John
Barry, author of The Great Influenza: The Epic Story of the
Deadliest Plague in History, will be open to the public the night
before, on Dec. 4.
Even though the primate center has had a
BSL3 for more than 20 years, a new facility like the RBL adds huge
cachet to the institution. "It's the same science," Roy says, "but you
know everybody likes to have nice digs to work in."
Share this article:
?